机译:澳大利亚Aspergillus Fumigatus临床和环境分离株的抗唑抗性监测及抗唑抗性分离物的同源性建模
Univ Sydney Sydney Sch Vet Sci Fac Sci Sydney NSW Australia;
Univ Sydney Westmead Hosp Ctr Infect Dis Westmead NSW Australia;
Univ Sydney Westmead Hosp Ctr Infect Dis Westmead NSW Australia;
Univ Sydney Fac Pharm Sydney NSW Australia;
Univ Sydney Fac Pharm Sydney NSW Australia;
Curtin Univ Sch Mol &
Life Sci Ctr Crop &
Dis Management Bentley WA Australia;
Curtin Univ Sch Mol &
Life Sci Ctr Crop &
Dis Management Bentley WA Australia;
Univ Sydney Plant Breeding Inst Cobbitty Judith &
David Coffey Chair Sustainable Agr Sydney NSW;
Elizabeth Macarthur Agr Inst NSW Dept Primary Ind Menangle Australia;
Univ Sydney Westmead Hosp Ctr Infect Dis Westmead NSW Australia;
Royal Hobart Hosp Dept Microbiol &
Infect Dis Hobart Tas Australia;
Univ Sydney Marie Bashir Inst Infect Dis &
Biosecur Westmead NSW Australia;
Univ Sydney Marie Bashir Inst Infect Dis &
Biosecur Westmead NSW Australia;
Univ Sydney Sydney Sch Vet Sci Fac Sci Sydney NSW Australia;
Univ Sydney Marie Bashir Inst Infect Dis &
Biosecur Westmead NSW Australia;
机译:澳大利亚Aspergillus Fumigatus临床和环境分离株的抗唑抗性监测及抗唑抗性分离物的同源性建模
机译:来自ARTEMIS全球监测研究的烟曲霉分离株的偶氮抗药性主要归因于cyp51A基因中的TR / L98H突变。
机译:非cyp51A耐唑类烟曲霉分离株具有HMG-CoA还原酶突变
机译:肠球菌临床分离株的耐药性研究,特别是高水平氨基糖苷抵抗,β内酰胺酶生产和耐药性横向转移
机译:底物结合环加氧酶-过氧化物酶超家族成员烟曲霉5,8-亚油酸二醇合酶和Gra草ver叶环加氧酶的同源性建模和生化特征。
机译:来自ARTEMIS全球监测研究的烟曲霉分离株的偶氮抗性主要归因于cyp51A基因的TR / L98H突变
机译:澳大利亚Aspergillus Fumigatus临床和环境分离株抗唑抗性的监测及抗唑抗性隔离物的同源性建模